Pharmaceuticals | Top 5 Selected Papers in 2022–2023 in the Section “Biopharmaceuticals”
17 April 2024
- “Cyclic Peptides in Pipeline: What Future for These Great Molecules?”
by Lia Costa, Emília Sousa and Carla Fernandes
Pharmaceuticals 2023, 16(7), 996; https://doi.org/10.3390/ph16070996
Available online: https://www.mdpi.com/1424-8247/16/7/996
- “Potential of Lactoferrin in the Treatment of Lung Diseases”
by Katarzyna Kaczyńska, Monika Jampolska, Piotr Wojciechowski, Dorota Sulejczak, Kryspin Andrzejewski and Dominika Zając
Pharmaceuticals 2023, 16(2), 192; https://doi.org/10.3390/ph16020192
Available online: https://www.mdpi.com/1424-8247/16/2/192
- “Trial of a Novel Oral Cannabinoid Formulation in Patients with Hypertension: A Double-Blind, Placebo-Controlled Pharmacogenetic Study”
by Ana Batinic, Davorka Sutlović, Sendi Kuret, Antonela Matana, Marko Kumric, Josko Bozic and Zeljko Dujic
Pharmaceuticals 2023, 16(5), 645; https://doi.org/10.3390/ph16050645
Available online: https://www.mdpi.com/1424-8247/16/5/645
- “MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway”
by Massimo Moro, Orazio Fortunato, Giulia Bertolini, Mavis Mensah, Cristina Borzi, Giovanni Centonze, Francesca Andriani, Daniela Di Paolo, Patrizia Perri, Mirco Ponzoni et al.
Pharmaceuticals 2022, 15(3), 297; https://doi.org/10.3390/ph15030297
Available online: https://www.mdpi.com/1424-8247/15/3/297
- “Strategies for Improving Peptide Stability and Delivery”
by Othman Al Musaimi, Lucia Lombardi, Daryl R. Williams and Fernando Albericio
Pharmaceuticals 2022, 15(10), 1283; https://doi.org/10.3390/ph15101283
Available online: https://www.mdpi.com/1424-8247/15/10/1283